Home/Filings/4/0001437749-23-008420
4//SEC Filing

Horvath Susan 4

Accession 0001437749-23-008420

CIK 0001029125other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 4:25 PM ET

Size

5.2 KB

Accession

0001437749-23-008420

Insider Transaction Report

Form 4
Period: 2023-03-27
Horvath Susan
V.P. of Finance & CFO
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-27+34,36934,369 total
    Exercise: $0.50Exp: 2033-03-27Common Stock (34,369 underlying)
Footnotes (1)
  • [F1]The option fully vests on March 20, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.

Issuer

Panbela Therapeutics, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001322846

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:25 PM ET
Size
5.2 KB